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A 49-year-old woman visited the clinic because of acute hepatitis and acute kidney
injury with decreased urine output presenting microscopic hematuria and protei-
nuria. An abdominal computed tomography revealed a localized, hypoattenuated
lesion in a hepatic lateral segment, and kidney biopsy showed oxalate crystal
deposition with tubular necrosis. In addition, the patient's 24-hour urinary excre-
tion of oxalate was increased. Her kidney and liver injury improved after sessions of
hemodialysis, and urinary oxalate excretion was normalized. Major mutations in
primary hyperoxaluria have not been proven. A full sequencing of target genes may
be helpful to diagnose a rare form of primary hyperoxaluria.
Copyright & 2015. The Korean Society of Nephrology. Published by Elsevier. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Although acute kidney injury (AKI) due to intratubular crystal
deposition can often occur in various clinical situations, oxalate
nephropathy is an unusual cause of acute or chronic renal failure.
Hyperoxaluria can develop in patients with inborn disorders of
oxalate metabolism (primary hyperoxaluria) or secondary to
other diseases (secondary hyperoxaluria) [1,2]. Primary hyperox-
aluria is a rare autosomal recessive inherited metabolic disease. In
primary hyperoxaluria, oxalate is overproduced, and nephrolithia-
sis repetitively occurs. Repetitive nephrocalcinosis can eventually
cause end-stage renal disease [1–4]. Liver enzymes that
speciﬁcally act on oxalate metabolism include alanine-glyoxylate
aminotransferase (AGT), glyoxylate reductase-hydroxypyruvate
reductase (GRHPR), and 4-hydroxy-2-oxoglutaratealdolase15. The Korean Society of Nep
.org/licenses/by-nc-nd/4.0/).
y, Department of Internal
-ro, Jung-gu, Seoul, 100-
Cha).(HOGA) [1]. Secondary hyperoxaluria can occur through several
pathways, including overingestion of oxalate or oxalate precur-
sors and increased absorption into the body through the intestinal
tract (e.g., ethylene glycol, inﬂammatory bowel disease, or pan-
creatic insufﬁciency) [2,5,6].
We report a patient with hyperoxaluria induced AKI and
acute hepatitis.
Case report
A 49-year-old woman visited our hospital because of right
upper quadrant discomfort and decreased urine output for
1 week. She denied having any previous medical problems, use
of regular medications, or intake of unusual foods or bev-
erages, with the exception of sorghum-derived Chinese liquor
1 week before the hospital visit. On admission, she had a blood
pressure of 150/80 mmHg, heart rate of 88 beats/min, body
temperature of 36.91C, and respiratory rate of 20 breaths/min.
Laboratory values on admission to the hospital were as
follows: white blood cell count, 8,400/mm3 with 81.1% ofhrology. Published by Elsevier. This is an open access article under the
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129 mEq/L; potassium, 4.0 mEq/L; chloride, 101 mEq/L; total
carbon dioxide, 17 mEq/L (anion gap 11); calcium, 8.1 mg/dL;
phosphorus, 8.6 mg/dL; uric acid, 6.0 mg/dL; blood urea nitro-
gen, 81 mg/dL; serum creatinine, 11.4 mg/dL; serum glutamic-
oxalocetic transaminase, 695 U/L; serum glutamic pyruvic
transaminase, 1,181 U/L; alkaline phosphatase, 117 U/L;Figure 1. Radiologic and pathologic ﬁndings. (A) Liver CT scan for the evalu
admission shows a localized hypoattenuated area in the lateral segment of t
the lesion (arrow; A2: nonenhanced image, A3: enhanced image). (B) Kidney
the glomeruli are evident (B1, PAS,100). Tubules focally reveal oxalate cry
interstitium exhibits focal moderate inﬂammatory cell inﬁltrates and ﬁbros
eosin; PAS, periodic acid-Schiff.
Figure 2. Changes in serum creatinine level and daily urine outpugamma-GT, 111 IU/L; total bilirubin, 1.6 mg/dL; albumin,
2.9 g/dL; partial thromboplastin time, 35.0 seconds; prothrom-
bin time (international normalized ratio), 0.97. The arterial
blood gas showed the following: pH 7.383; pCO2, 27.1 mmHg;
pO2, 84.7 mmHg; bicarbonate, 15.8 mmol/L.
Hepatitis A, B, and C serologies were negative. The abdominal
ultrasonography showed relatively homogeneous echogenicity ofation of liver function test (LFT) abnormality: liver CT scan at the time of
he liver (arrow; A1). CT scan after discharge shows the improvement of
biopsy results: No cellular crescents and no evidence of focal sclerosis of
stal deposits (arrow)(B2, PAS,200) with necrosis (B3, PAS,200). The
is (B4, H&E,200). CT, computed tomography; H&E, hematoxylin and
t throughout the hospital course. Bx., biopsy; HD, hemodialysis.
Kim et al / A rare case of hyperoxaluria 115the liver and no deﬁnite biliary dilatation. However, a none-
nhanced abdominal computed tomography (CT) showed a loca-
lized, hypoattenuated lesion in the hepatic lateral segment
suggesting acute hepatitis (Fig. 1A1).
The initial urinalysis showed 3þ protein, 10–19 red cells/
high power ﬁeld (HPF), and 1–4 white cells/HPF, and there
were no evident crystals. The serum C3 and C4 levels were
within normal limits. The antinuclear antibody test and anti-
neutrophil cytoplasmic antibody were also negative. Because
the patient had a kidney injury presenting as microscopic
hematuria and proteinuria, we performed a kidney biopsy on
the 5th day of admission to rule out glomerulonephritis. The
histopathological ﬁndings revealed focal oxalate crystal
deposition with tubule necrosis on light microscopy (Fig. 1B).
Under electron microscopic examination, the thickness of the
glomerular basement membrane was normal with partial
wrinkling, and there were no electron-dense deposits. Immu-
noﬂuorescence microscopy revealed no evidence of immune
complexes or autoantibody deposition.
Because urine output has been reduced and azotemia has
progressed, hemodialysis was started before the onset of
symptoms due to AKI or signs of renal failure. Her renal
function and urine output rapidly improved after several
sessions of hemodialysis in the ﬁrst 10 days of hospitalization
(Fig. 2).
An analysis of the patient’s 24-hour urine collection taken on
the 10th day of admission showed increased oxalate excretion
[oxalate 68 mg/24 h (reference: 4–31 mg/24 h), citrate 63 mg/
24 h (reference: Z150 mg/24 h), calcium 66mg/24 h (reference:
70–180 mg/24 h), and creatinine 0.9 g/24 h (reference: 0.8–2.0 g/
24 h)] (Table 1). On the 17th day of admission, a 24-hour urine
was collected again, and the laboratory values were as follows:
oxalate 20 mg/24 h, Ca 79.1 mg/24 h, and citrate 542 mg/24 h.
Because the possibility of secondary hyperoxaluria was low, a
genetic analysis for major mutations associated with primary
hyperoxaluria types 1 and 2 was performed. However, there
were no meaningful mutations (Table 2).
The patient was discharged 18 days after admission, and
visited the outpatient clinic at 1 week and 5 weeks after
discharge. Laboratory tests (liver panel, renal panel, urineTable 1. Laboratory ﬁndings for the 24-hour urine collection througho
Oxalate (mg/24 h) Citr
Initial (HOD 10) 68
1 wk later (HOD 17) 20
4 wk later (after discharge) 27
HOD, hospital day.
Table 2. Gene sequencing proﬁle of AGXT and GRPHPR
Nucleotide change
AGXT-8_AGXT-ex8_1F/R c.77744A-G
AGXT-8_AGXT-ex8_1F/R c.846þ170C-T
AGXT-9_10_AGXT-ex9-10_1F/R c.942þ138A-C
AGXT-11_AGXT-ex11_1F/R c.n289A-C
GRHPR-4_GRHPR-ex4_1F/R c.28811C-T
GRHPR-6_GRHPR-ex6_1F/R c.49468A-G
GRHPR-6_GRHPR-ex6_1F/R c.579A-G
There are no remarkable major mutations for primary hyperoxaluria types
Reference sequences used are NM 000030.2 and NM 012203.
AGXT, alanine-glyoxylate amino transferase gene; CDS, coding sequences; Ganalysis, and 24-hour urine oxalate excretion) were also
repeated. All laboratory values continued to improve, and the
24-hour urine oxalate excretion was 20 and 27 mg/24 h at
1 and 4 weeks after the initial 24-hour urine collection,
respectively. After renal function had normalized, an
enhanced abdominal CT scan was performed and showed an
improvement in the localized hypoattenuated lesion in the
hepatic lateral segment (Figs. 1A2 and 1A3).Discussion
Oxalate is the end product of ascorbic acid and glyoxalate in
catabolic metabolism in humans [1]. Excretion through the
kidney is the only way to eliminate oxalate because oxalate is
not metabolized in the human body. As excretion of oxalate
through the kidneys increases, oxalate crystals are deposited
in the tubular lumen and renal pelvis. This deposition leads to
impaired tubular epithelium, obstruction of the tubular lumen,
and recurrent urolithiasis, resulting in a deceased glomerular
ﬁltration rate [7].
In this patient, oxalate deposition was found on the kidney
biopsy, and increased oxalate excretion was conﬁrmed by the
24-hour urine collection. However, the patient had no history
of urinary calculi, and no speciﬁc ﬁndings of nephrolithiasis
were found by abdominal CT and ultrasonography. With
regard to secondary hyperoxaluria, the patient had no dietary
habits consistent with increased ingestion of oxalate or oxalate
precursors and showed no symptoms suggestive of gastro-
intestinal diseases causing oxalosis [2,5]. Moreover, symptoms
suggestive of ethylene glycol ingestion were not seen. In
addition, the patient was not an alcoholic, and the serum
anion gap was not elevated [6]. Collectively, these ﬁndings
suggested the possibility that primary hyperoxaluria led to
oxalate deposition. A genetic analysis for major mutations that
cause primary hyperoxaluria types 1 and 2 was then per-
formed, but no major mutations were detected [8–12].
However, the potential risk of primary hyperoxaluria can-
not be excluded. First, ﬁndings suggestive of secondary hyper-
oxaluria were not found in the patient’s history. Second, theut the clinical course
ate (mg/24 h) Ca (mg/24 h) Creatinine (g/24 h)
63 66.0 0.8
542 79.1 0.9
282 233.1 1.1
Amino acid change Zygosity Location
None Hetero Intron
None Hetero Intron
None Hetero Intron
None Hetero 30 UTR
None Homo Intron
None Homo Intron
p.Ala193¼ Homo CDS
1 and 2.
RPHPR, glyoxylate reductase; UTR, untranslated region.
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with a later progression than the typical clinical presentation
of primary hyperoxaluria remains [13].
The point that we should focus on is that the patient
presented with AKI related to oxalate crystal deposition and
acute hepatitis. One hypothesis to explain the present case is
that acute liver injury resulted in a deﬁciency of the liver-
speciﬁc enzymes related to glyoxylate-metabolism (e.g., AGT,
GRHPR), leading to increased oxalate formation. Then, oxalate
deposition resulted in renal tubule obstruction and AKI. Nota-
bly, the 24-hour urinary excretion of oxalate improved after
normalization of the liver enzymes. Many cases of hepatitis
accompanied by AKI have been reported. However, to our
knowledge, no previous reports have described metabolic
disorders controlled by liver enzymes associated with preceding
acute liver injury, especially in adults, although Reye-like
syndrome, an inherited metabolic disease, can present with
acute onset liver failure [14]. Additional studies on the tempor-
ary dysfunction of liver-speciﬁc enzymes due to hepatitis as a
cause of increased oxalate formation could be of broader
interest.
The progress of the patient will be observed by monitoring
renal function, signs of urolithiasis, and the urinary oxalate
excretion level because the cause of hyperoxaluria was not
well deﬁned. Moreover, we are planning to perform full
sequencing of the candidate genes for primary heperoxaluria
if a similar event occurs in the future. In some cases that have
been reported, no causative mutations were detected by
genetic analysis, despite the typical clinical manifestations of
primary hyperoxaluria. This result occurred because mutations
exist in promoters or other regulatory sequences or mutations
that have not yet been revealed exist, resulting in disrupted
metabolism. In the case of recurrence, we can also consider
performing a liver biopsy to evaluate the expression of AGT,
GRHPR, and HOGA to prove abnormal oxalate metabolism [15].
If crystal deposition is found on the kidney biopsy without
any evidence of other renal diseases, oxalosis should be
considered, and appropriate evaluations, including urine oxa-
late excretion, should be performed. If secondary hyperoxa-
luria can be excluded, primary hyperoxaluria should be
considered as a possibility, and evaluations, including genetic
analysis, should be performed.Conﬂict of interest
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